CNIR178X2201

Status: Active Trial | Marker: no marker Title A Phase II, multi-center, open label study of NIR178 in combination with PDR001 in patients with selected advanced solid tumors and non-Hodgkin lymphoma Study Number NCT03207867 Indication Histologically confirmed...

Bioluma

Status: Active Trial | Marker: no marker Title A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in relapsed lung cancer and to evaluate biomarkers predictive for response to immune checkpoint inhibition. Study Number...